<DOC>
	<DOCNO>NCT02147158</DOCNO>
	<brief_summary>This study evaluate superiority ulipristal acetate vs. placebo treatment bleed associate uterine fibroid</brief_summary>
	<brief_title>A Study Safety Efficacy Intermittent Ulipristal Treatment Abnormal Uterine Bleeding Associated With Leiomyomas</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<mesh_term>Uterine Hemorrhage</mesh_term>
	<criteria>Cyclic abnormal uterine bleeding ( heavy prolong ) . Menstrual blood loss ( MBL ) â‰¥ 80 mL first 8 day menses . Minimum one discrete leiomyoma observable transvaginal ultrasound . Evidence malignancy atypical nonatypical hyperplasia endometrial biopsy .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>